Does Medicare cover IYUZEH (adalimumab-biosimilar) injections?
Coverage depends on two things: whether IYUZEH is considered a covered drug under a beneficiary’s Part D plan (or Part B in specific situations), and whether it’s being used for an FDA-approved condition covered by that plan.
Is IYUZEH covered under Medicare Part D?
For most self-administered specialty drugs like IYUZEH, Medicare coverage generally happens through Part D (standalone prescription plans or Medicare Advantage Part D). Your plan must list IYUZEH on its formulary and apply any step therapy, prior authorization, or quantity limits.
Because Medicare Part D coverage rules vary by plan, the most accurate way to check is to:
- Look up IYUZEH on your plan’s formulary (drug list), and
- Check whether prior authorization or step therapy is required.
Could IYUZEH ever be covered under Medicare Part B?
Part B coverage is more common for drugs administered in a clinician’s office (or certain outpatient settings) under specific billing rules. If IYUZEH is billed as part of an outpatient service, coverage can vary by setting and provider billing practices. In many cases, however, these biologic/self-injectable medications are handled under Part D.
What you should do next to confirm coverage
To get a definitive answer for your situation, search your plan’s drug formulary for:
- The exact product name (IYUZEH), and
- The dosing form/strength listed on your prescription,
then confirm whether you need prior authorization.
If you share your Medicare plan type (Original Medicare + Part D, or Medicare Advantage) and your plan name, I can tell you what to look for in the rules that typically apply.
Source